Case of alemtuzumab-related alopecia areata management in MS

Neurol Neuroimmunol Neuroinflamm. 2018 Oct 19;6(1):e516. doi: 10.1212/NXI.0000000000000516. eCollection 2019 Jan.

Authors

Jillian K Chan¹, Anthony L Traboulsee¹, Ana-Luiza Sayao¹

Affiliation

¹ Department of Medicine (Neurology), University of British Columbia, Vancouver, British Columbia, Canada.

No abstract available

Publication types

Case Reports

MeSH terms

Adult
Alemtuzumab / adverse effects*
Alopecia Areata / chemically induced*
Female
Humans
Immunologic Factors / adverse effects*
Multiple Sclerosis, Relapsing-Remitting / drug therapy*

Substances

Immunologic Factors
Alemtuzumab